Preprint
Article
How to Analyze Cancer Progression in COVID-19 Pandemic?
This version is not peer-reviewed.
Submitted:
16 May 2020
Posted:
17 May 2020
You are already at the latest version
Abstract
The constant news about the corona virus is scary. It is not possible to separate treatment for Cancer due to COVID-19. An effective treatment comparison strategy is needed. We need to have a handy tool to understand cancer progression in this unprecedented scenario. Linking different events of cancer progression is the need of the hour. It is a methodological challenge. We provide the solutions to overcome the issue with interval between two consecutive events in motivating head and neck cancer (HNC) data.
Keywords:
COVID-19
; Accelerated Failure Time
; Proportional Hazard Model
; Bayesian
; Auto-Regression
Preprints on COVID-19 and SARS-CoV-2
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Downloads
401
Views
187
Comments
0
Subscription
Notify me about updates to this article or when a peer-reviewed version is published.
MDPI Initiatives
Important Links
© 2025 MDPI (Basel, Switzerland) unless otherwise stated